Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Vireo Growth Closes Schwazze Asset Deal to Expand Colorado and New Mexico Footprint

Tipranks - Wed Mar 25, 9:28AM CDT

Claim 30% Off TipRanks Premium

Vireo Growth ( (TSE:VREO) ) has provided an announcement.

Vireo Growth Inc., a U.S. cannabis operator with roots in medical marijuana, is building a nationally scaled but locally focused platform, hiring industry leaders and investing selectively in markets where it sees the strongest long‑term returns. The company positions itself as a disciplined consolidator in the cannabis sector, emphasizing operational execution and capital efficiency across its retail and production footprint.

Vireo has closed its acquisition of key assets from U.S. multi-state operator Schwazze, adding 24 dispensaries in Colorado, 21 in New Mexico, and one manufacturing facility in each state at an implied valuation of under four times pro forma EBITDA. The deal significantly expands Vireo’s retail presence in the Rocky Mountain region, brings on Schwazze executives Justin Dye and Forrest Hoffmaster to lead the Colorado and New Mexico operations, and marks an early step in a broader strategy to build a scaled retail network in those markets, potentially reshaping its competitive position and growth trajectory there.

More about Vireo Growth

Vireo Growth Inc., founded in 2014 as a pioneering medical cannabis company, operates a disciplined, execution-focused platform in the U.S. cannabis industry. The company combines an intense local market focus with the scale of a national portfolio, deploying capital and industry talent to build out retail and production assets while emphasizing long-term value for customers, employees, shareholders, and community stakeholders.

Average Trading Volume: 42,936

Technical Sentiment Signal: Strong Sell

Current Market Cap: C$583.4M

For a thorough assessment of VREO stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.